🇺🇸 FDA
Patent

US 9155798

Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents

granted A61KA61K38/1709A61K47/64

Quick answer

US patent 9155798 (Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents) held by Regents of the University of Minnesota expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/1709, A61K47/64, A61K47/642, A61K51/088